These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 16914848)

  • 1. Synaptic remodeling during aging and in Alzheimer's disease.
    Masliah E; Crews L; Hansen L
    J Alzheimers Dis; 2006; 9(3 Suppl):91-9. PubMed ID: 16914848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aβ-dependent reduction of NCAM2-mediated synaptic adhesion contributes to synapse loss in Alzheimer's disease.
    Leshchyns'ka I; Liew HT; Shepherd C; Halliday GM; Stevens CH; Ke YD; Ittner LM; Sytnyk V
    Nat Commun; 2015 Nov; 6():8836. PubMed ID: 26611261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synaptic retrogenesis and amyloid-beta in Alzheimer's disease.
    Wasling P; Daborg J; Riebe I; Andersson M; Portelius E; Blennow K; Hanse E; Zetterberg H
    J Alzheimers Dis; 2009; 16(1):1-14. PubMed ID: 19158416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synaptic Compensation as a Probable Cause of Prolonged Mild Cognitive Impairment in Alzheimer's Disease: Implications from a Transgenic Mouse Model of the Disease.
    Baazaoui N; Flory M; Iqbal K
    J Alzheimers Dis; 2017; 56(4):1385-1401. PubMed ID: 28222506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of synaptic pathology in Alzheimer's disease.
    Masliah E
    J Neural Transm Suppl; 1998; 53():147-58. PubMed ID: 9700653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synaptic degeneration in Alzheimer's disease.
    Arendt T
    Acta Neuropathol; 2009 Jul; 118(1):167-79. PubMed ID: 19390859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease.
    Jackson RJ; Rudinskiy N; Herrmann AG; Croft S; Kim JM; Petrova V; Ramos-Rodriguez JJ; Pitstick R; Wegmann S; Garcia-Alloza M; Carlson GA; Hyman BT; Spires-Jones TL
    Eur J Neurosci; 2016 Dec; 44(12):3056-3066. PubMed ID: 27748574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal death versus synaptic pathology in Alzheimer's disease.
    Bertoni-Freddari C; Fattoretti P; Solazzi M; Giorgetti B; Di Stefano G; Casoli T; Meier-Ruge W
    Ann N Y Acad Sci; 2003 Dec; 1010():635-8. PubMed ID: 15033803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD200 dysfunction in neuron contributes to synaptic deficits and cognitive impairment.
    Feng D; Huang A; Yan W; Chen D
    Biochem Biophys Res Commun; 2019 Sep; 516(4):1053-1059. PubMed ID: 31277944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease-related alterations in synaptic density: neocortex and hippocampus.
    Scheff SW; Price DA
    J Alzheimers Dis; 2006; 9(3 Suppl):101-15. PubMed ID: 16914849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synaptic Plasticity, Dementia and Alzheimer Disease.
    Skaper SD; Facci L; Zusso M; Giusti P
    CNS Neurol Disord Drug Targets; 2017; 16(3):220-233. PubMed ID: 28088900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presenilins and APP in neuritic and synaptic plasticity: implications for the pathogenesis of Alzheimer's disease.
    Chan SL; Furukawa K; Mattson MP
    Neuromolecular Med; 2002; 2(2):167-96. PubMed ID: 12428810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inside-out amyloid hypothesis and synapse pathology in Alzheimer's disease.
    Gouras GK; Willén K; Faideau M
    Neurodegener Dis; 2014; 13(2-3):142-6. PubMed ID: 24080821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential deregulation of NGF and BDNF neurotrophins in a transgenic rat model of Alzheimer's disease.
    Iulita MF; Bistué Millón MB; Pentz R; Aguilar LF; Do Carmo S; Allard S; Michalski B; Wilson EN; Ducatenzeiler A; Bruno MA; Fahnestock M; Cuello AC
    Neurobiol Dis; 2017 Dec; 108():307-323. PubMed ID: 28865749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics Strategies.
    Kamat PK; Kalani A; Rai S; Swarnkar S; Tota S; Nath C; Tyagi N
    Mol Neurobiol; 2016 Jan; 53(1):648-661. PubMed ID: 25511446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of C9orf72 in Microglia Drives Neuronal Injury by Enhancing Synaptic Pruning in Aged and Alzheimer's Disease Mice.
    Wang M; Jiang Y; Huang Z
    Neurosci Bull; 2022 Mar; 38(3):327-330. PubMed ID: 34783984
    [No Abstract]   [Full Text] [Related]  

  • 17. Structural plasticity of synapses in Alzheimer's disease.
    Adams IM
    Mol Neurobiol; 1991; 5(2-4):411-9. PubMed ID: 1823143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of synaptic dysfunction in Alzheimer's disease.
    Masliah E
    Histol Histopathol; 1995 Apr; 10(2):509-19. PubMed ID: 7599445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-mortem brain analyses of the Lothian Birth Cohort 1936: extending lifetime cognitive and brain phenotyping to the level of the synapse.
    Henstridge CM; Jackson RJ; Kim JM; Herrmann AG; Wright AK; Harris SE; Bastin ME; Starr JM; Wardlaw J; Gillingwater TH; Smith C; McKenzie CA; Cox SR; Deary IJ; Spires-Jones TL
    Acta Neuropathol Commun; 2015 Sep; 3():53. PubMed ID: 26335101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid beta: a putative intra-spinal microtubule-depolymerizer to induce synapse-loss or dentritic spine shortening in Alzheimer's disease.
    Mitsuyama F; Futatsugi Y; Okuya M; Karagiozov K; Peev N; Kato Y; Kanno T; Sano H; Koide T
    Ital J Anat Embryol; 2009; 114(2-3):109-20. PubMed ID: 20198823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.